Skip to Content

Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution

Last Updated: April 13, 2020
Status: Current

Products Affected - Description
    • Dorzolamide and Timolol ophthalmic solution, Akorn, 22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count, NDC 50383-0233-10
    • Dorzolamide and Timolol ophthalmic solution, Sandoz, 22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count, NDC 61314-0030-02
Reason for the Shortage
    • Akorn has dorzolamide and timolol ophthalmic solution available.
    • Sandoz did not provide a reason for the shortage.
    • Teva discontinued dorzolamide and timolol ophthalmic solution in April 2018.
    • Bausch Health had dorzolamide and timolol ophthalmic solution on shortage due to manufacturing delays.
Available Products
    • Cosopt ophthalmic solution, Akorn, 22.3 mg-6.8 mg/mL, 10 mL Ocumeter Plus bottle, 1 count, NDC 17478-0605-10
    • Cosopt PF ophthalmic solution, Akorn, 22.3 mg-6.8 mg/mL, 0.2 mL single-use preservative-free vial, 60 count, NDC 17478-0604-30
    • Dorzolamide and Timolol ophthalmic solution, Bausch Health, 22.3 mg-6.8 mg/mL, 10 mL bottle, 1 count, NDC 24208-0486-10

Estimated Resupply Dates

    • Akorn has dorzolamide/timolol 2%/0.5% ophthalmic solution in 10 mL bottles on allocation.
    • Sandoz has dorzolamide/timolol 2%/0.5% ophthalmic solution in 10 mL bottles on back order and the company cannot estimate a release date.

Implications for Patient Care

    • Each product contains dorzolamide hydrochloride 22.3 mg/mL (equivalent to dorzolamide 2%) and timolol maleate 6.8 mg/mL (equivalent to timolol 0.5%).

Updated

Updated April 13, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 30, 2017 by Benjamin Witt, PharmD, BCPS, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide